Control Bionics Bags A$1.04M To Expand Assistive Technology Solutions

Control Bionics Ltd (ASX: CBL) has received firm commitments to raise A$1.04 million via the issue of shares at A$0.043 each.

The placement was strongly supported by new investors and existing shareholders.

Wireless wearable device

CBL is a medical device company specialising in electromyography (EMG) solutions for assistive communication, mobility, and data measurement.

The company’s patented wireless wearable device (NeuroNode) detects minute signals sent from the brain to any skeletal muscle and is captured as EMG output.

This output is then sent wirelessly to a personal computer, enabling speech and other computer-controlled functions like email and texting.

Wheelchair module

Control Bionics recently extended its offering to mobility with the launch of DROVE – the autonomous wheelchair module.

DROVE allows powered users the independence to operate their wheelchairs in their own homes for the first time.

Growth strategy

This new funding will assist the company in achieving its global growth strategy with a focus through FY25 as follows:

  • Grow each of the 3 operating businesses (US, Australia, Japan) such that the selling operations in each market are EBITDA positive.
  • Build NeuroNode business globally.
  • Deliver first commercial sales of DROVE autonomous wheelchair controller.
  • Identify and execute on opportunities to more rapidly scale Control Bionics.
  • Commercialise the NeuroStrip and associated app.



JustStocks provides data and commentary that constitutes general information only. This does not constitute personal, financial or professional advice or assistance. The data and information compiled do not consider your investment objectives or your financial circumstances. JustStocks cannot guarantee this website’s accuracy, completeness, or timeliness. JustStocks accepts no responsibility regarding any inaccuracy, omission, or change in information or articles or the data provided. The information published on this site/page should not be relied upon as a substitute for personal financial or professional advice. The information provided may not be appropriate for your circumstances or needs. JustStocks recommends that you seek professional advice from a qualified advisor before you make any decisions.

Articles of Interest